DIANA IVEZAJ: Open Payments
NPI 1346910551 · ROSLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,082 in 46 payments from 10 companies in 2025. Trend: 2023 $1,087 · 2024 $1,023 · 2025 $1,082
Food & beverage: $1,082
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 16 | $390 |
| Amgen Inc. | 9 | $212 |
| HEARTFLOW, INC. | 5 | $125 |
| Esperion Therapeutics, Inc. | 4 | $87 |
| Novo Nordisk Inc | 3 | $68 |
| GlaxoSmithKline, LLC. | 2 | $49 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $48 |
| PFIZER INC. | 2 | $42 |
| Chiesi USA, Inc. | 2 | $36 |
| SCPHARMACEUTICALS INC. | 1 | $25 |
Products named: LEQVIO, REPATHA, FFRct, NEXLETOL, SHINGRIX, Kerendia, ELIQUIS, CLEVIPREX.
Industry payments across NY — which companies pay providers there.
